Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1

Interventions

Cytarabine 102 Cyclophosphamide 74 fludarabine 45 Idarubicin 39 Decitabine 36 Etoposide 35 Azacitidine 34 Methotrexate 31 Daunorubicin 30 Vincristine 28 Dexamethasone 27 venetoclax 25 Busulfan 24 Imatinib Mesylate 23 Radiotherapy 20 Mercaptopurine 20 Granulocyte Colony-Stimulating Factor 20 Dasatinib 19 Peripheral Blood Stem Cell Transplantation 18 Mitoxantrone 17 Doxorubicin 17 Immunotherapy, Adoptive 16 Rituximab 15 Asparaginase 15 Tretinoin 14 Cladribine 14 fludarabine phosphate 13 Prednisone 13 Prednisolone 13 Melphalan 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Spiritual Therapies × Other hematologic neoplasm × Clear all

NCT04412135 2020-06-02

SPIRIHEMATO

University Hospital, Limoges

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡